Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Prostate biopsy approach and complication rates

Title: Prostate biopsy approach and complication rates
Authors: Mate, Kinga; Nedjim, Saleh; Bellucci, S; Boucault, Cesar; Ghaffar, Nael; Constantini, Tracy; Marvanykovi, Fanni; Vestris, Pierre-Gilles; Sadreux, Yvanne; Laguerre, Mélanie; Stempfer, Gautier; Blanchet, Pascal; Istvan, Buzogany; Brureau, Laurent
Contributors: CHU Pointe-à-Pitre / Abymes Guadeloupe; CHU Ibn Rochd Casablanca; Université libre de Bruxelles (ULB); Institut de recherche en santé, environnement et travail (Irset); Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique EHESP (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes (Biosit : Biologie - Santé - Innovation Technologique)
Source: ISSN: 1792-1074.
Publisher Information: HAL CCSD; Spandidos Publications
Publication Year: 2023
Collection: Université de Rennes 1: Publications scientifiques (HAL)
Subject Terms: prostate biopsy; transrectal; transperineal; MRI-guided; complications; infections; hematuria; hematospermia; rectal bleeding; urinary retention; sepsis; [SDV]Life Sciences [q-bio]
Description: International audience ; Prostate biopsy is the gold standard to confirm prostate cancer. In addition to standard 12-core biopsies, magnetic resonance imaging (MRI)-guided prostate biopsies have recently been introduced to improve the detection of clinically significant prostate cancer. The present study aimed to compare the complications after standard transrectal ultrasound-guided and standard plus targeted (MRI-guided) prostate biopsies, to study the impact of the number of biopsy cores on complication rates, and to compare complication rates after transrectal ultrasound-guided prostate biopsies with those following transperineal prostate biopsies from the literature. A prospective study was performed, which included 135 patients who underwent transrectal ultrasound-guided prostate biopsies between April 1 and June 30, 2022, at the Urology Department of the University Hospital of Pointe a Pitre (Pointe a Pitre, Guadeloupe). A total of 51 patients were excluded because of missing information concerning their post-biopsy surveillance. The median age at the time of biopsy was 69 years, median prostate-specific antigen value was 8.9 ng/ml, median prostate volume was 57.5 ml, and median number of cores was 15. A total of 35 of the 84 included patients (41.7%) had a standard biopsy only and 49 (58.3%) had targeted (MRI-guided) plus standard biopsies. A total of 53 patients (63.1%) experienced early side effects, whereas only 24 patients (28.6%) experienced late side effects. Three patients (3.6%) required hospitalization for post-biopsy complications. Early side effects, especially hematuria and hematospermia, occurred significantly more frequently in the targeted plus standard group, with more cores taken, with no significant difference concerning late side effects or infectious complications between the standard and standard plus targeted groups. The admission rate for sepsis after transperineal biopsy has been reported to vary between 0 and 1%, whereas the present study had an admission rate of 2.29% using the ...
Document Type: article in journal/newspaper
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/37559580; PUBMED: 37559580; PUBMEDCENTRAL: PMC10407705
DOI: 10.3892/ol.2023.13959
Availability: https://hal.science/hal-04191214; https://hal.science/hal-04191214v1/document; https://hal.science/hal-04191214v1/file/ol_26_3_13959_PDF.pdf; https://doi.org/10.3892/ol.2023.13959
Rights: http://creativecommons.org/licenses/by-nc-nd/ ; info:eu-repo/semantics/OpenAccess
Accession Number: edsbas.4D5FEC2E
Database: BASE